gadoterate meglumine

Term ID

CHEBI:73727

Synonyms

1-deoxy-1-(methylazaniumyl)-D-glucitol [2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl-kappa(4)N(1),N(4),N(7),N(10))tetraacetato(4-)]gadolinate(1-)
[2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl-kappa(4)N(1),N(4),N(7),N(10))tetraacetato(3-)]gadolinium--1-deoxy-1-(methylamino)-D-glucitol (1/1)
Gadolinium-DOTA meglumine
Gd-DOTA meglumine
Meglumine gadopentate
Meglumine gadoterate

(all 6)

Definition

An organoammonium salt obtained by reaction of gadoteric acid with one equivalent of 1-deoxy-1-(methylamino)-D-glucitol (meglumine). It is used in magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues of patients ages 2 years and older, to detect and visualise areas with disruption of the blood brain barrier and/or abnormal vascularity of the central nervous system.

References

(all 21)

Ontology

ChEBI ( EBI )

Relationships

is a type of: gadolinium coordination entity organoammonium salt

gadolinium coordination entity organoammonium salt Show first 5 Terms
has_part: gadoterate

gadoterate Show first 5 Terms
has_role: MRI contrast agent

MRI contrast agent Show first 5 Terms

Phenotype

Phenotype resulting from gadoterate meglumine

Phenotype where environments contain gadoterate meglumine

Phenotype modified by environments containing gadoterate meglumine

Phenotype affecting gadoterate meglumine

Human Disease Model